STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G/A] Oric Pharmaceuticals, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Viking Global and affiliated entities report a passive 9.99% position in Oric Pharmaceuticals (ORIC). The Schedule 13G/A shows Viking Global Investors LP and related funds and entities collectively beneficially own 8,729,345 shares of Oric common stock on a fully reported basis, equal to 9.99% of 85,224,191 shares outstanding (May 29, 2025 basis). Holdings arise from directly owned common stock plus pre-funded warrants exercisable for additional shares, but exercise is limited by a contractual "Blocker" that caps beneficial ownership at 9.99% (adjustable up to 19.99% with notice). Ownership is held through VGOP and VGOD (detailed share and warrant counts provided), VGI provides managerial services and has shared voting/dispositive authority, and three named executives are disclosed as having shared authority. The filing certifies the stake is not intended to influence control.

Positive

  • Transparent disclosure of a sizable economic stake (8,729,345 shares, 9.99%)
  • Clear description of share vs. warrant holdings and application of the contractual Blocker
  • Filing includes Item 10 certification confirming passive intent (not to influence control)

Negative

  • None.

Insights

TL;DR: Viking Global discloses a sizeable near-10% passive stake in ORIC via common stock and warrants, constrained by a 9.99% blocker.

The position of 8,729,345 shares (9.99%) is economically meaningful for a company with ~85.2 million shares outstanding and could be a significant shareholder block without signaling an active control intent—the filing is on Schedule 13G/A and includes an Item 10 certification that the holdings are not for control purposes. The presence of warrants increases potential upside exposure, but the Blocker currently prevents additional exercises beyond the stated cap. For modeling ownership concentration, treat this as a large passive stake with potential to increase subject to contractual limitations and notice periods.

TL;DR: Governance impact is limited now—shared voting power is disclosed, but the filing affirms a passive intent and a blocker restricts control escalation.

The filing identifies shared voting and dispositive power across multiple affiliated entities and three Executive Committee members, which is standard for fund structures. The Blocker mechanism legally constrains conversion of warrants into additional voting shares above 9.99% absent a notice and waiting period, reducing immediate governance pressure. Because the filing is a 13G/A with the Item 10 certification, this should not be treated as an activist or control-oriented disclosure, though the aggregated economic stake is large enough to be relevant in takeover or voting scenarios.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G




Comment for Type of Reporting Person: See Item 4


SCHEDULE 13G



VIKING GLOBAL INVESTORS LP
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of VIKING GLOBAL INVESTORS LP (1)(2)(3)
Date:08/14/2025
Viking Global Opportunities Parent GP LLC
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Opportunities Parent GP LLC (1)(2)(3)
Date:08/14/2025
Viking Global Opportunities GP LLC
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Opportunities GP LLC (1)(2)(3)
Date:08/14/2025
Viking Global Opportunities Portfolio GP LLC
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Opportunities Portfolio GP LLC (1)(2)(3)
Date:08/14/2025
Viking Global Opportunities Illiquid Investments Sub-Master LP
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Opportunities Illiquid Investments Sub-Master LP (1)(2)(3)
Date:08/14/2025
Viking Global Opportunities Drawdown GP LLC
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Opportunities Drawdown GP LLC (1)(2)(3)
Date:08/14/2025
Viking Global Opportunities Drawdown Portfolio GP LLC
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Opportunities Drawdown Portfolio GP LLC (1)(2)(3)
Date:08/14/2025
Viking Global Opportunities Drawdown (Aggregator) LP
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Viking Global Opportunities Drawdown (Aggregator) LP (1)(2)(3)
Date:08/14/2025
HALVORSEN OLE ANDREAS
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of O. Andreas Halvorsen (1)
Date:08/14/2025
Ott David C.
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of David C. Ott (2)
Date:08/14/2025
Shabet Rose Sharon
Signature:/s/ Scott M. Hendler
Name/Title:Scott M. Hendler on behalf of Rose S. Shabet (3)
Date:08/14/2025

Comments accompanying signature: (1) Scott M. Hendler is signing on behalf of O. Andreas Halvorsen, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, VIKING GLOBAL OPPORTUNITIES DRAWDOWN GP LLC, VIKING GLOBAL OPPORTUNITIES DRAWDOWN PORTFOLIO GP LLC and VIKING GLOBAL OPPORTUNITIES DRAWDOWN (AGGREGATOR) LP, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commission as an exhibit to a Form 13G filed by Mr. Halvorsen on February 12, 2021 (SEC File No. 005-49737). (2) Scott M. Hendler is signing on behalf of David C. Ott, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, VIKING GLOBAL OPPORTUNITIES DRAWDOWN GP LLC, VIKING GLOBAL OPPORTUNITIES DRAWDOWN PORTFOLIO GP LLC and VIKING GLOBAL OPPORTUNITIES DRAWDOWN (AGGREGATOR) LP, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commission as an exhibit to a Form 13G filed by Mr. Halvorsen on February 12, 2021 (SEC File No. 005-49737). (3) Scott M. Hendler is signing on behalf of Rose S. Shabet, individually and as an Executive Committee Member of VIKING GLOBAL PARTNERS LLC, on behalf of VIKING GLOBAL INVESTORS LP, and as an Executive Committee Member of VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, on behalf of itself and VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, VIKING GLOBAL OPPORTUNITIES DRAWDOWN GP LLC, VIKING GLOBAL OPPORTUNITIES DRAWDOWN PORTFOLIO GP LLC and VIKING GLOBAL OPPORTUNITIES DRAWDOWN (AGGREGATOR) LP, pursuant to an authorization and designation letter dated February 9, 2021, which was previously filed with the Commission as an exhibit to a Form 13G filed by Mr. Halvorsen on February 12, 2021 (SEC File No. 005-49737).
Exhibit Information

EXHIBIT A - JOINT FILING AGREEMENT

FAQ

How many Oric Pharmaceuticals (ORIC) shares do Viking Global and affiliates report owning?

The Reporting Persons disclose beneficial ownership of 8,729,345 shares of ORIC common stock, representing 9.99% of 85,224,191 shares outstanding (May 29, 2025 basis).

Does the Schedule 13G/A include warrants in the ownership calculation for ORIC?

Yes. The filing counts directly owned common stock plus pre-funded warrants exercisable into common stock, but exercise rights are limited by a contractual Blocker that caps ownership at 9.99% unless adjusted with notice.

Which Viking entities hold the ORIC position and how are the shares allocated?

Holdings are through VGOP (4,312,800 shares plus rights to 1,293,987 shares via warrants) and VGOD (2,259,900 shares plus rights to 862,658 shares via warrants), with aggregate reporting by VGI and related GP/portfolio entities.

Does this filing indicate Viking Global seeks to influence control of Oric Pharmaceuticals?

No. Item 10 of the filing certifies that the securities were not acquired and are not held for the purpose of changing or influencing control; the Schedule filed is a 13G/A (passive) filing.

What is the Blocker and how does it affect potential warrant exercises?

The Blocker prevents holders from exercising warrants to the extent that exercise would cause beneficial ownership to exceed 9.99% (the blocker can be adjusted up to 19.99% with notice, effective after a 61-day delay).
Oric Pharmaceuticals, Inc.

NASDAQ:ORIC

ORIC Rankings

ORIC Latest News

ORIC Latest SEC Filings

ORIC Stock Data

1.13B
87.20M
6.94%
99.21%
8.42%
Biotechnology
Pharmaceutical Preparations
Link
United States
SOUTH SAN FRANCISCO